press release

Noble Further Expands Capabilities of Its New Human Factors + Program

By Bill Guilliouma | June 8, 2021
Posted in ,

HF+ gaining momentum with additional offerings, successful support for new drug launches and expert hiring ORLANDO, Fla. (June 8, 2021) – In direct response to the rapid growth of the… Read More »

Noble and Aptar Pharma Launch AdhereIT®, a Connected Medical Device Solution for Disease Management, Adherence and Onboarding Patients

By Bill Guilliouma | October 5, 2020
Posted in , , , , , , , , ,

Crystal Lake, Illinois and Orlando, Florida (October 5, 2020) — Noble and Aptar Pharma are pleased to announce the launch of AdhereIT® — a connected, intuitive and user-friendly onboarding solution… Read More »

Noble Appoints Executive Director of Marketing & Patient Services

By Bill Guilliouma | June 24, 2020
Posted in

Tim McLeroy is an industry pioneer with a groundbreaking career in product development and marketing for global pharmaceutical brands ORLANDO, Fla. (June 24, 2020) – Noble, an Aptar Pharma company,… Read More »

Nemera and Noble Announce Collaboration to Support Patients Who Self-Administer Medication

By Bill Guilliouma | June 16, 2020
Posted in

Nemera, world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, today announced a collaboration with Noble, the global leader in medical… Read More »

Noble Names Aptar Executive to Director of Account Management

By Bill Guilliouma | May 7, 2020
Posted in

Noble Names Aptar Executive to Director of Account Management Newly-created position will focus on representing the customers’ interests and maximizing Noble’s value by bringing solutions to customer challenges ORLANDO, Fla…. Read More »

Telemedicine Gains Acceptance Amid the COVID-19 Pandemic

By Bill Guilliouma | May 5, 2020
Posted in

ORLANDO, Fla. (April 30, 2020) – Telemedicine is poised to become a mainstream alternative to the traditional in-person methods of care delivery, with the COVID-19 pandemic easing barriers to acceptance… Read More »